These advertisements highlighted Trulicitys ease of use, long-lasting effects, and A1C impact as well as promoting the non-insulin nature of the drug and the convenience of the pens hidden needle with the Click to activate your within, tagline
Choose Medisafe or MyTherapy for generic medication reminders unrelated to GLP-1
The FDA issued a cluster of warning letters targeting multiple companies for selling unapproved GLP-1related peptide products, often marketed for weight loss or metabolic benefits, without proper approval
District Court in New York unsealed a March 2025 complaint filed by Gilead Sciences against a pharmacy in Queens, New York alleged to have sold counterfeit Biktarvy, an HIV treatment, and refused to disclose its source
10.2337/diab.29.7.583 44
Multiple studies have shown reductions in inflammatory markers among people taking GLP-1 agonists, and patients frequently report improvements in inflammation-related conditions